NCT06383078 2024-04-25HR070803 in Combination With Oxaliplatin, S-1 Versus NALIRIFOX as Adjuvant Therapy for Pancreatic CancerThe First Affiliated Hospital with Nanjing Medical UniversityPhase 2 Not yet recruiting120 enrolled